Papers
1
Total Citations
7
H-Index
1
About
Dr. A. Germann is a leading immunologist whose work centers on advancing immune monitoring technologies for clinical and vaccine research. Their major contribution lies in pioneering the standardization and automation of the ELISpot assay, a critical tool for detecting T cell responses. In their highly cited 2016 paper, "Towards standardized automated immunomonitoring," Dr. Germann addressed the pressing need for reproducibility and operator safety in clinical trials. By developing a parallelized, automated system, they significantly reduced inter- and intra-assay variability, enabling more reliable comparisons of immune function across global studies. This work has been cited 7 times, reflecting its foundational role in improving assay quality. Dr. Germann’s achievements include enhancing the safety and efficiency of immunomonitoring, directly impacting vaccine evaluation and immunotherapy development. Their research continues to shape best practices in cellular immunology, offering students and researchers a robust framework for consistent, high-quality immune analysis.
Research Focus
Key Achievements
Top Papers
- 1